Published in J Exp Med on February 01, 1984
Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov (2010) 4.47
High resolution two-dimensional electrophoresis of basic as well as acidic proteins. Cell (1977) 30.04
Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood (1975) 15.95
Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer (1976) 14.08
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst (1972) 10.15
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res (1968) 7.53
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci U S A (1976) 6.82
Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood (1979) 6.01
Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med (1976) 5.05
Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci U S A (1978) 3.99
Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture. Cancer Res (1981) 3.62
Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med (1979) 3.43
Cell surface antigens of human malignant melanoma. III. Recognition of autoantibodies with unusual characteristics. J Exp Med (1977) 3.42
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol (1970) 3.17
EB virus-induced B lymphocyte cell lines producing specific antibody. Nature (1977) 2.56
Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens. J Exp Med (1981) 2.53
Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci U S A (1980) 2.35
Production of human hybridomas secreting antibodies to measles virus. Nature (1980) 2.32
A human-hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukemia-derived line. Eur J Immunol (1982) 2.17
Generation of human monoclonal antibodies reactive with human mammary carcinoma cells. Proc Natl Acad Sci U S A (1980) 1.86
Generation of human monoclonal antibodies reactive with cellular antigens. Proc Natl Acad Sci U S A (1983) 1.71
Monoclonal antibodies that detect differentiation surface antigens on human myelomonocytic cells. Blood (1982) 1.57
Immunoglobulin binding by mouse intestinal epithelial cell receptors. J Immunol (1976) 1.57
Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma. J Exp Med (1983) 1.48
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual. J Exp Med (1982) 1.36
Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines. Proc Natl Acad Sci U S A (1982) 1.21
Myeloid differentiation antigen defined by a monoclonal antibody. Blood (1981) 1.12
Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas. J Exp Med (1982) 1.09
Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens. Blood (1982) 1.08
Antibody producing human-human hybridomas. I. Technical aspects. J Immunol Methods (1983) 0.95
Monoclonal antibodies reactive with acute myelogenous leukemia cells. J Immunol (1981) 0.82
Cloning of human hybridoma, myeloma and lymphoma cell lines using enriched human monocytes as feeder layer. J Immunol Methods (1983) 0.81
Phenotypic diversity in leukemia cell populations. Cancer Metastasis Rev (1983) 0.81
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab (1998) 5.06
Ultrastructural features of Mycoplasma pneumoniae. J Bacteriol (1970) 3.84
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut (2000) 3.69
A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med (1995) 3.30
Fuel ethanol production from lignocellulose: a challenge for metabolic engineering and process integration. Appl Microbiol Biotechnol (2001) 3.27
Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol (1991) 3.15
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (1989) 2.93
Cytomegalovirus infection of human blood cells. J Infect Dis (1984) 2.38
The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol (2000) 2.36
Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity. Proc Natl Acad Sci U S A (1980) 2.35
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science (1988) 2.30
Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand (1991) 2.29
Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol (1978) 2.29
Science and government. Navigating the anthropocene: improving Earth system governance. Science (2012) 2.19
Network identification and flux quantification in the central metabolism of Saccharomyces cerevisiae under different conditions of glucose repression. J Bacteriol (2001) 2.18
Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst (1999) 2.18
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
Ontogenetic scaling of foraging rates and the dynamics of a size-structured consumer-resource model. Theor Popul Biol (1998) 2.03
The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med (1999) 1.98
Increasing NADH oxidation reduces overflow metabolism in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2007) 1.89
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol (1986) 1.88
Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical, and histological study. Gut (1986) 1.87
Metabolic engineering of Saccharomyces cerevisiae. Microbiol Mol Biol Rev (2000) 1.82
Intracerebral inflammation after human brain contusion. Neurosurgery (1998) 1.82
Diversity of Holocene life forms in fossil glacier ice. Proc Natl Acad Sci U S A (1999) 1.82
A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab (1999) 1.75
Specifically cytotoxic lymphocytes produced by preincubation with antibody-complexed target cells. J Immunol (1972) 1.74
Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. Hum Mol Genet (1996) 1.74
Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF. Exp Cell Res (1990) 1.72
Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol (1997) 1.72
Brains and faces in holoprosencephaly: pre- and postnatal description of 30 cases. Ultrasound Obstet Gynecol (2002) 1.66
Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer (1997) 1.65
Habitat preference among amylase genotypes in Asellus aquaticus (Isopoda, Crustacea). Hereditas (1977) 1.63
Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res (1997) 1.55
Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis (2006) 1.53
Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden. Cancer Causes Control (1993) 1.51
Uropod formation in phytohaemagglutinin (PHA) stimulated lymphocytes. Exp Cell Res (1971) 1.47
The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens. Proc Natl Acad Sci U S A (1986) 1.44
[Magnetic tomography of the central nervous system in adults with myelomeningocele]. Tidsskr Nor Laegeforen (1998) 1.44
Serum homocysteine concentration as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med (2000) 1.43
Myelodysplastic syndrome following epipodophyllotoxin therapy in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol (1993) 1.43
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Altered DNA ligase III activity in the CHO EM9 mutant. Mutat Res (1994) 1.42
Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res (2004) 1.42
MALA-2, mouse homologue of human adhesion molecule ICAM-1 (CD54). Eur J Immunol (1989) 1.37
The risk of colorectal cancer in ulcerative colitis. An epidemiologic study. Scand J Gastroenterol (1987) 1.37
Glucose control in Saccharomyces cerevisiae: the role of Mig1 in metabolic functions. Microbiology (1998) 1.37
Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res (1985) 1.36
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer (1988) 1.34
Photogating of ionic currents across a lipid bilayer. Proc Natl Acad Sci U S A (1989) 1.31
A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 1.31
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease. J Clin Invest (1997) 1.30
Simplicity-correlated size growth of the nuclear 28S ribosomal RNA D3 expansion segment in the crustacean order Isopoda. J Mol Evol (1996) 1.30
Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res (1999) 1.28
Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network. Nat Biotechnol (2000) 1.27
Cost analysis of ethanol production from willow using recombinant Escherichia coli. Biotechnol Prog (1994) 1.26
Potential inhibitors from wet oxidation of wheat straw and their effect on ethanol production of Saccharomyces cerevisiae: wet oxidation and fermentation by yeast. Biotechnol Bioeng (2003) 1.25
The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells. Eur J Immunol (1979) 1.23
Morphological observations on the cytotoxicity of human bood lymphocytes for antibody-coated chicken erythrocytes. Exp Cell Res (1970) 1.22
Increased occurrence of cytoplasmic filaments in in vitro propagated rat liver epithelial cells. Exp Cell Res (1965) 1.22
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model. Br J Haematol (1997) 1.22
An immunohistological study of human lymphoma. Clin Exp Immunol (1980) 1.21
Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand A (1987) 1.21
IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]. J Virol Methods (1988) 1.20
Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol (1995) 1.19
Technical aspects of lymphoma immunohistology. J Histochem Cytochem (1980) 1.17
A predictive model for the clinical response to low dose ara-C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia. Br J Haematol (1992) 1.16
Comparative genomic hybridization in clinical cytogenetics. Am J Hum Genet (1995) 1.15
Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology (2001) 1.13
Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer (1986) 1.13
Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia (2007) 1.11
Simultaneous overexpression of enzymes of the lower part of glycolysis can enhance the fermentative capacity of Saccharomyces cerevisiae. Yeast (2000) 1.10
Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun (1998) 1.10
Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proc Natl Acad Sci U S A (1984) 1.10
Alleviation of glucose repression of maltose metabolism by MIG1 disruption in Saccharomyces cerevisiae. Appl Environ Microbiol (1996) 1.10
Sex differences in posttraumatic cytokine release of endotoxin-stimulated whole blood: relationship to the development of severe sepsis. J Trauma (2000) 1.09
Lipid and lipoprotein distributions in white children ages 6-19 yr. The Lipid Research Clinics Program Prevalence Study. J Chronic Dis (1981) 1.08
Reduction of postoperative morbidity and mortality in patients with rectal cancer following the introduction of a colorectal unit. Br J Surg (2001) 1.08
Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood (1985) 1.08
Cytotoxic interaction of phytohemagglutinin-stimulated blood lymphocytes with monolayer cells: a study by light and electron microscopy. Cell Immunol (1971) 1.08
Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J Neurochem (1994) 1.07
Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.07
Referral from general practice to specialists in Denmark. J R Coll Gen Pract (1986) 1.06
Intracerebral inflammatory response to experimental brain contusion. Acta Neurochir (Wien) (1995) 1.06
Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation. Blood (1984) 1.06
Different patterns of X inactivation in MZ twins discordant for red-green color-vision deficiency. Am J Hum Genet (1992) 1.06
Image analysis in comparative genomic hybridization. Cytometry (1995) 1.05
KBM-7, a human myeloid leukemia cell line with double Philadelphia chromosomes lacking normal c-ABL and BCR transcripts. Leukemia (1995) 1.05
Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation. Clin Exp Immunol (1974) 1.05
In vivo dynamics of galactose metabolism in Saccharomyces cerevisiae: metabolic fluxes and metabolite levels. Biotechnol Bioeng (2001) 1.05
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices. Scand J Gastroenterol (2001) 1.05
Investigation of the impact of MIG1 and MIG2 on the physiology of Saccharomyces cerevisiae. J Biotechnol (1999) 1.04
Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am J Pathol (1990) 1.04
Insulinomimetic effect on glucose transport by epidermal growth factor when combined with a major histocompatibility complex class I-derived peptide. J Biol Chem (1993) 1.04